These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2284253)

  • 81. Inability of dimethyl sulfoxide to increase brain uptake of water-soluble compounds: implications to chemotherapy for brain tumors.
    Greig NH; Sweeney DJ; Rapoport SI
    Cancer Treat Rep; 1985 Mar; 69(3):305-12. PubMed ID: 3978658
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Influence of O-(beta-hydroxyethyl)-rutoside or venoruton on lactate dehydrogenase of human cultured varicose veins.
    Matagne D; Hamoir G
    Biochem Pharmacol; 1975 Aug; 24(16):1491-4. PubMed ID: 1191306
    [No Abstract]   [Full Text] [Related]  

  • 83. No effect of O-(beta-hydroxyethyl)-rutoside on red cell filterability in patients with acute myocardial infarction.
    Waldenlind L; Edlund BL; Hulting J; Lund F
    J Intern Med; 1990 Dec; 228(6):655-6. PubMed ID: 2280245
    [No Abstract]   [Full Text] [Related]  

  • 84. Evaluation of anesthetic effects on parameters for the in situ rat brain perfusion technique.
    Rousselle CH; Lefauconnier JM; Allen DD
    Neurosci Lett; 1998 Dec; 257(3):139-42. PubMed ID: 9870339
    [TBL] [Abstract][Full Text] [Related]  

  • 85. [Intravenous application of hylase "Dessau" on the blood-brain barrier].
    Senitz D; Fischer GJ
    Exp Pathol (Jena); 1972; 7(5):228-33. PubMed ID: 4660914
    [No Abstract]   [Full Text] [Related]  

  • 86. An indicator-dilution technique for study of blood-to-brain solute passage in the rat.
    Murray JE; Plioplys A
    J Appl Physiol; 1972 Nov; 33(5):681-3. PubMed ID: 4564473
    [No Abstract]   [Full Text] [Related]  

  • 87. Endothelial negative surface charge areas and blood-brain barrier function.
    Hardebo JE; Kåhrström J
    Acta Physiol Scand; 1985 Nov; 125(3):495-9. PubMed ID: 4083048
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Pharmacological modification of blood-brain barrier permeability following a cold lesion.
    Raymond JJ; Robertson DM; Dinsdale HB; Nag S
    Can J Neurol Sci; 1984 Nov; 11(4):447-51. PubMed ID: 6518427
    [TBL] [Abstract][Full Text] [Related]  

  • 89. TIMP-2 reduces proteolytic opening of blood-brain barrier by type IV collagenase.
    Rosenberg GA; Kornfeld M; Estrada E; Kelley RO; Liotta LA; Stetler-Stevenson WG
    Brain Res; 1992 Apr; 576(2):203-7. PubMed ID: 1381261
    [TBL] [Abstract][Full Text] [Related]  

  • 90. The effect of chronic low level lead exposure on blood-brain barrier function in the developing rat.
    Moorhouse SR; Carden S; Drewitt PN; Eley BP; Hargreaves RJ; Pelling D
    Biochem Pharmacol; 1988 Dec; 37(23):4539-47. PubMed ID: 3144282
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Brain glucose transport and phosphorylation under acute insulin-induced hypoglycemia in mice: an 18F-FDG PET study.
    Alf MF; Duarte JM; Schibli R; Gruetter R; Krämer SD
    J Nucl Med; 2013 Dec; 54(12):2153-60. PubMed ID: 24159048
    [TBL] [Abstract][Full Text] [Related]  

  • 92. [Correlations of pharmacokinetics and pharmacodynamics of a combined preparation containing pyrrolidone and pyroglutamic acid].
    Sariev AK; Lun'shina EV; Zherdev VP; Mirzoian NR
    Eksp Klin Farmakol; 2006; 69(2):58-61. PubMed ID: 16845944
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Hepatocyte growth factor attenuates cerebral ischemia-induced increase in permeability of the blood-brain barrier and decreases in expression of tight junctional proteins in cerebral vessels.
    Date I; Takagi N; Takagi K; Tanonaka K; Funakoshi H; Matsumoto K; Nakamura T; Takeo S
    Neurosci Lett; 2006 Oct; 407(2):141-5. PubMed ID: 16973272
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Water, electrolytes contents of the brain and cerebral function in aged rats.
    Cahn J; Borzeix MG
    Monogr Neural Sci; 1984; 11():85-92. PubMed ID: 6330542
    [No Abstract]   [Full Text] [Related]  

  • 95. Blood-brain barrier dysfunction after amphetamine administration in rats.
    Carlsson C; Johansson BB
    Acta Neuropathol; 1978 Feb; 41(2):125-9. PubMed ID: 636843
    [No Abstract]   [Full Text] [Related]  

  • 96. Anesthesia and cerebrospinal microcirculation: assessment using cranial- and spinal-window techniques.
    Iida H; Iida M; Takenaka M
    J Anesth; 2012 Feb; 26(1):143-6. PubMed ID: 22101772
    [No Abstract]   [Full Text] [Related]  

  • 97. The blood-brain barrier: an overview with special reference to insulin effects on glucose transport.
    Barry DI; Paulson OB; Hertz MM
    Acta Neurol Scand Suppl; 1980; 78():147-56. PubMed ID: 7025551
    [No Abstract]   [Full Text] [Related]  

  • 98. Antipermeability effects of some corticosteroids.
    Bapat SK; Jauhari AC; Mishra SS; Ansari KU; Chandra V
    Indian J Med Sci; 1970 Nov; 24(11):737-41. PubMed ID: 5490365
    [No Abstract]   [Full Text] [Related]  

  • 99. Dendropanax morbifera Léveille extract ameliorates cadmium-induced impairment in memory and hippocampal neurogenesis in rats.
    Kim W; Yim HS; Yoo DY; Jung HY; Kim JW; Choi JH; Yoon YS; Kim DW; Hwang IK
    BMC Complement Altern Med; 2016 Nov; 16(1):452. PubMed ID: 27829466
    [TBL] [Abstract][Full Text] [Related]  

  • 100. The bioflavonoid O-(beta-hydroxyethyl)-rutoside affects the cerebral metabolism and the permeability of the blood-brain barrier in the rat.
    Saija A; Princi P; De Pasquale R; Costa G
    Pharmacol Res; 1990; 22 Suppl 1():69-70. PubMed ID: 2284253
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.